Jadelle sub-dermal implant: evaluation of acceptance, effectiveness, side effects and discontinuation in Ilorin, Nigeria

No Thumbnail Available



Journal Title

Journal ISSN

Volume Title


School of Medicine, Kenyatta University, Kenya


Objective: To determine the safety, efficacy, acceptability, side effects and discontinuation pattern of Jadelle® subdermal implant.Design: A retrospective descriptive study. Setting: The Family Planning Clinic of the University of Ilorin Teaching Hospital [UITH], Ilorin, Kwara State, Nigeria. Subjects: All clients who accepted Jadelle® sub-dermal implant between 1st January 2008 and 31st December 2012. Data was collected from the individual patient case files and analysed using SPSS version 20. Main outcome measures: The prevalence, efficacy, side effects and discontinuation among users of Jadelle®. Results: Of the 2,324 clients during the study period, 108 chose Jadelle® with prevalence of 4.7%. Among these acceptors, 23 (21.3%) had side-effects following insertion. The commonest side effect was menstrual irregularities (60.9%). Twelve acceptors (11.1%) discontinued before the due date for the removal of the insert. Insertion after oneyear from last childbirth (p 0.021) andtwo or more side effects (p 0.001) were significant predictors of discontinuation while previous contraceptive use, number of children alive and age were statistically insignificant. The pearl index was 0 during the study period. Conclusion: Jadelle® is an acceptable contraceptive and the side effects are tolerable to most clients in the study.



Jadelle, sub-dermal implant, contraceptive effectiveness, discontinuation